LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Artificial Sweeteners May Promote Development of Glucose Intolerance and Weight Gain

By LabMedica International staff writers
Posted on 01 Oct 2014
Image: Electron microscope image of a healthy mouse small intestine showing bacteria (strings) surrounding the gut villi (protrusions). A human small intestine looks very similar (Photo courtesy of the Weizmann Institute of Science).
Image: Electron microscope image of a healthy mouse small intestine showing bacteria (strings) surrounding the gut villi (protrusions). A human small intestine looks very similar (Photo courtesy of the Weizmann Institute of Science).
Recently published findings have stirred a controversy by indicating that noncaloric artificial sweeteners (NAS), a key components of diet drinks and foods, actually promote development of glucose intolerance, metabolic disease, and obesity by causing profound changes in the composition and function of the organisms that make up the intestinal microbiome (gut microbiota).

Investigators at the Weizmann Institute of Science (Rehovot, Israel) worked with mouse models as well as evaluating data accumulated by the Personalized Nutrition Project, a large human trial probing the connection between nutrition and the microbiota.

They reported in the September 17, 2014, online edition of the journal Nature that consumption of commonly used NAS formulations drove the development of glucose intolerance through induction of compositional and functional alterations to the intestinal microbiota. These NAS-mediated deleterious metabolic effects were reversed by antibiotic treatment, and were fully transferable to germ-free mice upon fecal transplantation of microbiota configurations from NAS-consuming mice. Similar changes were observed in anaerobic cultures of organisms from the gut microbiota that were grown in the presence of NAS.

The investigators identified NAS-altered microbial metabolic pathways that were linked to host susceptibility to metabolic disease, and demonstrated similar NAS-induced microbial imbalance and glucose intolerance in healthy human subjects.

Senior author Dr. Eran Elinav, professor of immunology at the Weizmann Institute of Science, said, "Certain bacteria in the guts of those who developed glucose intolerance reacted to the chemical sweeteners by secreting substances that then provoked an inflammatory response similar to sugar overdose, promoting changes in the body’s ability to utilize sugar. Our relationship with our own individual mix of gut bacteria is a huge factor in determining how the food we eat affects us. Especially intriguing is the link between use of artificial sweeteners, through the bacteria in our guts, to a tendency to develop the very disorders they were designed to prevent; this calls for reassessment of today’s massive, unsupervised consumption of these substances.”

Related Links:

Weizmann Institute of Science
Personalized Nutrition Project


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more